Real World Stage II-III NSCLC Patients Receiving Neoadjuvant Chemo-immunotherapy and no Surgical Resection | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Real World Stage II-III NSCLC Patients Receiving Neoadjuvant Chemo-immunotherapy and no Surgical Resection	Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm	Recruiting	Not stated	2025-08-20		NCT07131163

11 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Gustave Roussy, Cancer Campus, Grand Paris	93
Hadassah Medical Organization	53
Mayo Clinic	970
MedStar Georgetown University Hospital	3
Rabin Medical Center	33
Rambam Health Care Campus	34
Sheba Medical Center	63
Soroka University Medical Center	10
Tel-Aviv Sourasky Medical Center	55
University Hospital, Geneva	108
UOMi Cancer Center	2

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Jusidman Cancer Center, Sheba Medical Center	Ramat Gan	Israel	1